ConductScience.org, home

Paper36919124

The Prevalence of CHEK1 and CHEK2 Mutations in Prostate Cancer: a Retrospective Cohort Study.

Alorjani M and 7 others. Med Arch, 2023. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. The Prevalence of CHEK1 and CHEK2 Mutations in Prostate Cancer: a Retrospective Cohort Study. Papers, record 36919124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36919124

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Prevalence of CHEK1 and CHEK2 Mutations in Prostate Cancer: a Retrospective Cohort Study.
PubMed
Journal
Med Arch
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.57
iCite
Revised in PubMed
2025-12-12
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alorjani MMohammed
2Aburub MManar
3Al-Trad BBahaa
4Hamad MAMohammad Al
5AbuAlarja MManal
6Bashir SASamir Al
7Al-Batayneh KKhalid
8Zoubi MAMazhar Al

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic NeoplasmsMajor topic
Male
Humans
Germ-Line Mutation
Checkpoint Kinase 1
Prevalence
Retrospective Studies
Checkpoint Kinase 2

Source PubMed

Download CSV of topics

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112533788Mutations in CHEK2 associated with prostate cancer risk.Am J Hum Genet2003https://conductscience.org/library/papers/12533788PubMed
225583358CHEK2 mutations and the risk of papillary thyroid cancer.Int J Cancer2015https://conductscience.org/library/papers/25583358PubMed
315131084Collaboration of Brca1 and Chk2 in tumorigenesis.Genes Dev2004https://conductscience.org/library/papers/15131084PubMed
430614821PTEN Loss in a Prostate Cancer Cohort From Jordan.Appl Immunohistochem Mol Morphol2020https://conductscience.org/library/papers/30614821PubMed
511746983Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors.Genes Chromosomes Cancer2002https://conductscience.org/library/papers/11746983PubMed
627425814High frequency of gene mutations in metastatic prostate cancer.Lancet Oncol2016https://conductscience.org/library/papers/27425814PubMed
718162465ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.J Biol Chem2008https://conductscience.org/library/papers/18162465PubMed
815539958Chk1 is essential for tumor cell viability following activation of the replication checkpoint.Cell Cycle2005https://conductscience.org/library/papers/15539958PubMed
928067867Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.Nat Commun2017https://conductscience.org/library/papers/28067867PubMed
1023296741The risk of gastric cancer in carriers of CHEK2 mutations.Fam Cancer2013https://conductscience.org/library/papers/23296741PubMed
1114678969The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.Cancer Res2003https://conductscience.org/library/papers/14678969PubMed
1210617473Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.Science1999https://conductscience.org/library/papers/10617473PubMed
1323157136[Epidemiology and risk factors of the prostate cancer].Pol Merkur Lekarski2012https://conductscience.org/library/papers/23157136PubMed
1419230643Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.Curr Opin Cell Biol2009https://conductscience.org/library/papers/19230643PubMed
159744884The Xenopus Chk1 protein kinase mediates a caffeine-sensitive pathway of checkpoint control in cell-free extracts.J Cell Biol1998https://conductscience.org/library/papers/9744884PubMed
1626629066CHEK2 mutation and risk of prostate cancer: a systematic review and meta-analysis.Int J Clin Exp Med2015https://conductscience.org/library/papers/26629066PubMed
1714612911CHEK2 variants associate with hereditary prostate cancer.Br J Cancer2003https://conductscience.org/library/papers/14612911PubMed
1816899408DNA damage-induced cell death by apoptosis.Trends Mol Med2006https://conductscience.org/library/papers/16899408PubMed
1920592345TP53 gene mutations in prostate cancer progression.Anticancer Res2010https://conductscience.org/library/papers/20592345PubMed
2010859164Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.Genes Dev2000https://conductscience.org/library/papers/10859164PubMed

See all 42 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42025253Ataxia telangiectasia mutated (ATM) kinase as a predictive biomarker in clinical oncology: implications for a precision treatment approach.Neoplasia2026https://conductscience.org/library/papers/42025253PubMed
40434671FOXM1 Promotes Non-Small Cell Lung Cancer Progression by Increasing CHEK1 Expression.Curr Med Sci2025https://conductscience.org/library/papers/40434671PubMed
40344565Predicting breast cancer prognosis based on a novel pathomics model through CHEK1 expression analysis using machine learning algorithms.PLoS One2025https://conductscience.org/library/papers/40344565PubMed
40247989DEP domain‑containing 1 is a prognostic biomarker associated with the cell cycle in gliomas.Oncol Lett2025https://conductscience.org/library/papers/40247989PubMed
40116118Role of multi‑omics in advancing the understanding and treatment of prostate cancer (Review).Mol Med Rep2025https://conductscience.org/library/papers/40116118PubMed
39329938Novel Mutations in AKT1 Gene in Prostate Cancer Patients in Jordan.Curr Issues Mol Biol2024https://conductscience.org/library/papers/39329938PubMed
37970346Whole Exome Sequencing reveals clinically important pathogenic mutations in DNA repair genes across lung cancer patients.Am J Cancer Res2023https://conductscience.org/library/papers/37970346PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36919124

GET https://conductscience.org/api/papers/v1/36919124/references?page=2